Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Vaginal Neoplasms

fluorodeoxyglucose f18 has been researched along with Vaginal Neoplasms in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (42.86)29.6817
2010's9 (42.86)24.3611
2020's3 (14.29)2.80

Authors

AuthorsStudies
Duarte, LH; Gouveia, P; Nunes, S; Petiz, A; Sá Pinto, A; Teixeira, R; Violante, L1
Albuquerque, KS; Bernardo, GCO; D'Ippolito, G; de Araújo, EM; Gomes, NBN; Lewin, F; Libânio, BB; Pedroso, MHNI; Racy, DJ; Souza E Silva, TX; Torres, US; Zoghbi, KK1
Kuang, A; Pan, L; Shen, G; Wang, R1
Bhosale, PR; Devine, C; Faria, S; Javadi, S; Korivi, BR; Viswanathan, C1
Beriwal, S; Comerci, JT; Courtney-Brooks, M; Edwards, RP; Gebhardt, BJ; Glaser, SM; Houser, CJ; Kelley, JL; Kim, H; Olawaiye, AB; Sukumvanich, P; Vargo, JA1
Chen, X; Fu, Z; Li, Q; Yang, X1
Fan, Q; Liu, H; Su, M; Wang, R1
Adams, R; Debernardo, R; Dowlati, A; Faulhaber, P; Fusco, N; Kunos, CA; Radivoyevitch, T; Redline, R; Resnick, K; Waggoner, S; Zanotti, K1
Abu-Rustum, NR; Benz, M; Hricak, H; Lyons, G; Robertson, NL; Sala, E; Sonoda, Y; Sosa, RE; Vargas, HA1
Atmaca Saglik, B; Basoglu, T; Sahin, M; Ucak Semirgin, S; Yapici, O1
Bentivegna, E; Duvillard, P; Gouy, S; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Uzan, C1
Kahr, HS; Lund, B; Mejlgaard, E1
Bourguet, P1
Carp, L; De Beeck, BO; Tjalma, WA1
Bridji, B; Oudoux, A; Resche, I; Rousseau, C; Rousseau, T1
Fulham, MJ; Mohamed, A; Thambugala, GM1
Dehdashti, F; Gibb, RK; Grigsby, PW; Lamoreaux, WT; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Zoberi, I1
Dehdashti, F; Gao, F; Gibb, RK; Grigsby, PW; Herzog, TJ; Huettner, PC; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Wright, JD1
Grahek, D; Talbot, JN1
Akhurst, T; Alektiar, K; Barakat, RR; Chi, DS; Husain, A; Larson, S1

Reviews

3 review(s) available for fluorodeoxyglucose f18 and Vaginal Neoplasms

ArticleYear
Vaginal cancer: Why should we care? Anatomy, staging and in-depth imaging-based review of vaginal malignancies focusing on MRI and PET/CT.
    Clinical imaging, 2022, Volume: 84

    Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Vaginal Neoplasms

2022
FDG-PET Assessment of Other Gynecologic Cancers.
    PET clinics, 2018, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms

2018
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in gynecological neoplasms].
    Bulletin du cancer, 2003, Volume: 90 Spec No

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms

2003

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Vaginal Neoplasms

ArticleYear
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.
    Gynecologic oncology, 2013, Volume: 130, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Cisplatin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Pyridines; Thiosemicarbazones; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms

2013

Other Studies

17 other study(ies) available for fluorodeoxyglucose f18 and Vaginal Neoplasms

ArticleYear
18F-FDG PET/CT in Patients with Vulvar and Vaginal Cancer: A Preliminary Study of 20 Cases.
    Acta medica portuguesa, 2022, Mar-02, Volume: 35, Issue:3

    Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Vaginal Neoplasms

2022
Malignant Extrarenal Rhabdoid Tumor of the Vagina on FDG PET/CT.
    Clinical nuclear medicine, 2021, Dec-01, Volume: 46, Issue:12

    Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Rhabdoid Tumor; Vaginal Neoplasms

2021
Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
    Gynecologic oncology, 2018, Volume: 150, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Treatment Outcome; Vaginal Neoplasms

2018
Diagnosis of Primary Clear Cell Carcinoma of the Vagina by 18F-FDG PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:4

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Vaginal Neoplasms

2019
Isolated Vaginal Recurrence of Early-Stage Rectal Cancer Detected by 18F-FDG PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:6

    Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Vaginal Neoplasms

2019
The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer.
    Gynecologic oncology, 2016, Volume: 140, Issue:3

    Topics: Carcinoma; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Vaginal Neoplasms; Vulvar Neoplasms

2016
Diagnostic value of additional 18F-FDG PET/CT imaging using a vaginal catheter in patients with paravaginal malignant lesions.
    Nuclear medicine communications, 2016, Volume: 37, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Catheters; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vagina; Vaginal Neoplasms

2016
[The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers].
    Gynecologie, obstetrique & fertilite, 2011, Volume: 39, Issue:4

    Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Uterine Cervical Neoplasms; Vaginal Neoplasms; Young Adult

2011
[Primary malignant melanoma of the vagina].
    Ugeskrift for laeger, 2013, Jan-14, Volume: 175, Issue:3

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Vaginal Neoplasms

2013
False-positive positron emission tomographic scan and computed tomography for recurrent vaginal cancer: pitfalls of modern imaging techniques.
    Gynecologic oncology, 2004, Volume: 92, Issue:2

    Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Vaginal Neoplasms

2004
[2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers].
    Gynecologie, obstetrique & fertilite, 2004, Volume: 32, Issue:4

    Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Neoplasm, Residual; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms

2004
Interest of F-18 fluorodeoxyglucose positron emission tomography in the evaluation of vaginal malignant melanoma.
    Gynecologic oncology, 2004, Volume: 95, Issue:3

    Topics: Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Vaginal Neoplasms

2004
Vaginal melanoma mimicking bladder FDG activity in a patient with chronic renal failure.
    Clinical nuclear medicine, 2005, Volume: 30, Issue:6

    Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Failure, Chronic; Melanoma; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Diseases; Vaginal Neoplasms

2005
FDG-PET evaluation of vaginal carcinoma.
    International journal of radiation oncology, biology, physics, 2005, Jul-01, Volume: 62, Issue:3

    Topics: Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Vaginal Neoplasms

2005
Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
    Cancer, 2005, Dec-01, Volume: 104, Issue:11

    Topics: Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Nodes; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Vaginal Neoplasms

2005
[Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers].
    Gynecologie, obstetrique & fertilite, 2006, Volume: 34, Issue:5

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms

2006
A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
    Gynecologic oncology, 2007, Volume: 106, Issue:1

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Exenteration; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms

2007